Bone mineral density and disorders of mineral metabolism in chronic liver disease

World Journal of Gastroenterology

Volumn 15, Issue 28, 2009, Pages 3516-3522

  George, Joe ^a   Ganesh, Hosahithlu K ^a   Acharya, Shrikrishna ^a   Bandgar, Tushar R ^a   Shivane, Vyankatesh ^a   Karvat, Anjana ^a   Bhatia, Shobna J ^a   Shah, Samir ^b   Menon, Padmavathy S ^a   Shah, Nalini ^a  

^a KEM HOSPITAL   (India)

^b JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Bone mineral density; Bone mineral metabolism; Chronic disease; Cirrhosis; Hepatic osteodystrophy; Liver disease

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM PHOSPHATE; DEOXYPYRIDINOLINE; ESTRADIOL; MAGNESIUM; OSTEOCALCIN; PHOSPHATE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; ESTROGEN; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN;

ADULT; ALCOHOLISM; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY MASS; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CHRONIC LIVER DISEASE; CREATININE BLOOD LEVEL; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPOGONADISM; INCIDENCE; INDIA; LIVER CIRRHOSIS; LIVER FUNCTION; LUMBAR SPINE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; MINERAL METABOLISM; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; RISK ASSESSMENT; RISK FACTOR; SUNLIGHT; VITAMIN D DEFICIENCY; CHRONIC DISEASE; DIET; LIVER DISEASE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CHRONIC DISEASE; DIET; ESTROGENS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LIVER DISEASES; MALE; MIDDLE AGED; MOTOR ACTIVITY; SUNLIGHT; YOUNG ADULT;

EID: 70349572321     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3516     Document Type: Article

References (25)

1. Hay JE. Osteoporosis in liver diseases and after liver transplantation. J Hepatol 2003; 38: 856-865
2. Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002; 50 Suppl 1: i1-i9
3. Hay JE, Guichelaar MM. Evaluation and management of osteoporosis in liver disease. Clin Liver Dis 2005; 9: 747-766, viii
4. Sachdev S, Bhasin RC, Kumari CK, Reys M. A study of metabolic bone disorder in cirrhosis liver. J Assoc Physicians India 1976; 24: 5-11
5. Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 2002; 87: 4952-4956
6. Nutrient requirements and recommended daily allowances for Indians: Report of the expert group of the Indian Council of Medical Research. National Institute of Nutrition, 2000: 41
7. Leslie WD, Bernstein CN, Leboff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003; 125: 941-966
8. Mithal A. Metabolic bone disorders. 1st ed. Indian society of bone and mineral research, 1998: 213-219
9. Nordin BE. International patterns of osteoporosis. Clin Orthop Relat Res 1966; 45: 17-30
10. Vernejoul M. Bone structure and function. In: Geusens P, editor. Osteoporosis in clinical practice. A practical guide for diagnosis and treatment. London: Springer-Verlag, 1998: 1-4
11. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997; 60: 148-154
12. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28: 695-699
13. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990; 31: 82-87
14. Khosla S, Melton LJ 3rd, Riggs BL. Clinical review 144: Estrogen and the male skeleton. J Clin Endocrinol Metab 2002; 87: 1443-1450
15. Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, Bolognesi M, Gatta A. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition 1997; 13: 185-190
16. Caufriez A, Reding P, Urbain D, Golstein J, Copinschi G. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest 1991; 14: 317-321
17. Shmueli E, Stewart M, Alberti KG, Record CO. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis. Hepatology 1994; 19: 322-328
18. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994; 9: 915-921
19. Tsuneoka K, Tameda Y, Takase K, Nakano T. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 1996; 31: 669-678
20. Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M. Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 2000; 45: 1392-1399
21. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993; 234: 249-255
22. Cemborain A, Castilla-Cortazar I, Garcia M, Quiroga J, Muguerza B, Picardi A, Santidrian S, Prieto J. Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol 1998; 28: 122-131
23. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319
24. Scharf JG, Schmitz F, Frystyk J, Skjaerbaek C, Moesus H, Blum WF, Ramadori G, Hartmann H. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 1996; 25: 689-699
25. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995; 21: 680-688